Skip to content
DefDex

Federal award

BIOFIRE DIAGNOSTICS LLC

W81K0020P0348

Contract

Obligated and Ceiling

Obligated (net)
$3,588,711.30
Ceiling (potential value, not spending)
$4,529,271.70
Current value
$4,529,271.70
Gross positive obligations
$3,767,261.28

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BIOFIRE DIAGNOSTICS LLC · TBBNREFT3LD3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
COMPAGNIE MERIEUX ALLIANCE · WG3DJHG5C1C7
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0020P0348
Award type code
B
Actions
18 · Sep 26, 2020 to Sep 2, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History18

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 2, 2025FY2025P00017B−$363.19
—
Aug 26, 2025FY2025P00016C−$113,924.51
—
Nov 20, 2024FY2025P00015C$933,148.13
—
Oct 21, 2024FY2025P00014C$16,065.57
—
Sep 25, 2024FY2024P00013C$5,355.19
—
Sep 20, 2024FY2024P00012C−$64,262.28
—
Aug 8, 2024FY2024P00011G$0.00
—
Jul 10, 2024FY2024P00010B$0.00
—
Nov 30, 2023FY2024P00009C$937,564.13
—
May 2, 2023FY2023P00008G$0.00
—
Nov 1, 2022FY2023P00007C$937,564.13
—
Jul 18, 2022FY2022P00006G$0.00
—
Dec 14, 2021FY2022P00005C$937,564.13
—
Jul 22, 2021FY2021P00004G$0.00
—
May 11, 2021FY2021P00003M$0.00
—
Feb 23, 2021FY2021P00002M$0.00
—
Nov 9, 2020FY2021P00001C$0.00
—
Sep 26, 2020FY20200—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.